INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 158 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,470,204 | -22.5% | 46,496 | 0.0% | 0.01% | -14.3% |
Q2 2023 | $1,896,107 | +15.5% | 46,496 | +5.6% | 0.01% | +16.7% |
Q1 2023 | $1,641,035 | +6.8% | 44,031 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $1,536,242 | -31.5% | 44,031 | +9.8% | 0.01% | -36.8% |
Q3 2022 | $2,244,052 | +10.6% | 40,101 | +2.3% | 0.02% | +11.8% |
Q2 2022 | $2,028,164 | -25.3% | 39,184 | +4.9% | 0.02% | -5.6% |
Q1 2022 | $2,715,097 | -4.9% | 37,362 | +54.7% | 0.02% | -25.0% |
Q4 2021 | $2,855,851 | -11.9% | 24,153 | 0.0% | 0.02% | -20.0% |
Q3 2021 | $3,240,125 | -12.2% | 24,153 | +6.0% | 0.03% | -14.3% |
Q2 2021 | $3,688,957 | +130.5% | 22,784 | +14.2% | 0.04% | +133.3% |
Q1 2021 | $1,600,525 | +47.5% | 19,943 | 0.0% | 0.02% | +36.4% |
Q4 2020 | $1,084,899 | +173.6% | 19,943 | 0.0% | 0.01% | +175.0% |
Q3 2020 | $396,467 | -5.4% | 19,943 | 0.0% | 0.00% | -20.0% |
Q2 2020 | $419,202 | +117.8% | 19,943 | +26.7% | 0.01% | +66.7% |
Q1 2020 | $192,512 | -16.6% | 15,741 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $230,920 | +9.9% | 15,741 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $210,142 | -18.4% | 15,741 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $257,680 | -4.2% | 15,741 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $268,856 | +25.1% | 15,741 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $214,865 | -52.3% | 15,741 | 0.0% | 0.00% | -40.0% |
Q3 2018 | $450,507 | +4.5% | 15,741 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $431,000 | +169.4% | 15,741 | +107.2% | 0.01% | +150.0% |
Q1 2018 | $160,000 | +9.6% | 7,597 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $146,000 | – | 7,597 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |